Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PRFX PainReform Ltd. Ordinary Shares
$2.12 -6.36% -0.15
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PRFX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.6M
Enterprise value -1645325
Trailing PE 0.014849499
Forward PE -0.17247097
PEG Ratio -0.17247097
Enterprise to EBITDA 0.378
Enterprise to revenue -96.784
Price to book MRQ 0.20223626
Price to sales TTM 95.810646

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2024-06-30
Revenue (TTM) 17000
EBITDA -4348000
Diluted EPS TTM -7.47
Total Cash (MRQ) 4.1M
Current ratio (MRQ) 1.782
Operating Cash Flow (TTM) -3955000

PRFX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PRFX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.